Morton Collins, Director at INOVIO PHARMACEUTICALS, INC. (INO), bought 50,000 shares at $0.59 ($30K) on 2011-06-29, disclosed to the SEC on 2011-06-29.
Open-market purchase of $30k INO by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| INO | BUY | 2017-03-28 | $133K | — | Filing → |
| INO | BUY | 2016-06-29 | $183K | — | Filing → |
| KOPN | BUY | 2016-05-20 | $106K | — | Filing → |